Marco Gambarotti

23PUBLICATIONS
174CO-AUTHORS
Rheumatology and arthritisMolecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 27, 2026
Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.

Agnieszka E Zając, Piotr Rutkowski, Anna Szumera-Ciećkiewicz

|Nov 13, 2025
Establishment and Characterization of OS-MET-R-092: A Novel Patient-Derived Cell Culture from an Osteosarcoma Bone Metastasis.

Veronica Giusti, Leonardo Fantoni, Monica Torsello

|Aug 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.

Emanuela Palmerini, Cristina Meazza, Angela Tamburini

|Jul 25, 2025
Tumor Immune Microenvironment-Associated Prognostic and Mifamurtide-Response Gene Signatures for Localized Osteosarcoma: A Correlative Study of the ISG/OS-2 Trial.

Emanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri

Pageof 4